Oculis Holding AG (OCS) Operating Leases (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Operating Leases of $2.3 million in Q1 2026, up 3.25% quarter-over-quarter from $2.3 million in Q4 2025, and up 163.25% on a YoY basis from $888688.2 in Q1 2025.
Oculis Holding AG (OCS) Operating Leases (2021 - 2026) Analysis & Trends
Oculis Holding AG's Operating Leases history runs 6 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Operating Leases rose 163.25% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 163.25% YoY), while the FY2025 annual figure was $2.3 million, up 129.47% from the prior year.
- Operating Leases was $2.3 million for Q1 2026 at Oculis Holding AG, up from $2.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.6 million in Q3 2025 to a low of $470875.4 in Q1 2024.
- Historically, Operating Leases has averaged $1.2 million across 5 years, with a median of $888688.2 in 2025.
- The sharpest annual moves came in 2025 and 2026: Operating Leases fell 22.21% in 2025, then jumped 163.25% in 2026.
- A 5-year view of Operating Leases shows it stood at $657067.9 in 2022, then increased by 3.8% to $682049.5 in 2023, then surged by 44.77% to $987416.4 in 2024, then surged by 129.47% to $2.3 million in 2025, then advanced by 3.25% to $2.3 million in 2026.
- The last three Operating Leases figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 869,680.96 |
| Mar 31, 2025 | 888,688.18 |
| Dec 31, 2024 | 987,416.40 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 470,875.43 |
| Dec 31, 2023 | 682,049.46 |
| Sep 30, 2023 | 571,737.04 |
| Jun 30, 2023 | 599,462.62 |
| Dec 31, 2022 | 657,067.87 |
| Dec 31, 2021 | 625,757.71 |